All Updates

All Updates

icon
Filter
Management news
OPGen receives delisting notice from Nasdaq after failing to meet compliance requirements
Precision Medicine
Aug 23, 2024
This week:
Partnerships
T-Mobile partners with OpenAI to develop AI-powered customer service platform
Generative AI Applications
Yesterday
Partnerships
Runway partners with Lionsgate to develop AI video tools using studio's movie catalog
Generative AI Applications
Sep 18, 2024
Funding
QMill raises EUR 4 million in seed funding to provide quantum computing industrial applications
Quantum Computing
Sep 18, 2024
Product updates
QuiX Quantum launches 'Bia' quantum cloud computing service for quantum solutions
Quantum Computing
Sep 18, 2024
Partnerships
Oxford Ionics and Infineon Technologies partner to build portable quantum computer for Cyberagentur
Quantum Computing
Sep 18, 2024
Partnerships
Product updates
Tencent Ai Lab launches EzAudio AI for text-to-audio generation with Johns Hopkins University
Foundation Models
Sep 18, 2024
Funding
TON secures USD 30 million in investment from Bitget and Foresight Ventures
Web3 Ecosystem
Sep 18, 2024
Funding
Hemi Labs raises USD 15 million in funding to launch blockchain network
Web3 Ecosystem
Sep 18, 2024
Product updates
Fivetran launches Hybrid Deployment for data pipeline management
Machine Learning Infrastructure
Sep 18, 2024
Product updates
Fivetran launches Hybrid Deployment for data pipeline management
Data Infrastructure & Analytics
Sep 18, 2024
Precision Medicine

Precision Medicine

Aug 23, 2024

OPGen receives delisting notice from Nasdaq after failing to meet compliance requirements

Management news

  • Nasdaq has suspended trading of OpGen shares after the company failed to provide an adequate plan to regain compliance with the stock exchange's listing requirements. OpGen has been grappling with multiple challenges, including outstanding debt and the recent bankruptcies of its European subsidiaries, Curetis and Ares Genetics.

  • Earlier this year, OpGen attempted to regain compliance by implementing a one-for-10 reverse stock split to meet Nasdaq’s USD 1 minimum bid price requirement. However, the company faced further setbacks when it failed to file a first-quarter report with the US Securities and Exchange Commission (SEC) and fell short of the Nasdaq’s minimum stockholders’ equity requirement. Despite submitting the overdue report and proposing a plan to regain compliance, the Nasdaq hearing board rejected the plan, leading to the suspension of trading.

  • In its financial situation, OpGen recently struck a deal to sell up to USD 3 million in common stock to AEI Capital, aiming to boost its shareholder equity and meet Nasdaq's requirements. However, with the suspension of its shares, the status of this deal remains uncertain, and company officials have not provided further comments.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.